Bio Details

Lisa M. Giles founded Giles & Associates Consultancy, Inc. (GAC) to serve the life sciences industry and academic medical centers since 2000. She is the firm’s Managing Director and Chief Executive Officer. Her career has spanned more than 35 years in the pharmaceutical, diagnostic, medical device, and healthcare industries and included extensive experience in enterprise strategic planning, and R&D and commercial planning. Ms. Giles has also served on the Boards of Directors of several public companies. She currently serves as an independent director on the Board of Directors for Milestone Pharmaceuticals (MIST) and the Northwestern Memorial Health System Foundation Board. Previously, she served on the Boards of Directors for GenMark Diagnostics (GNMK) from 2015 to 2021; Durata Therapeutics, Inc. from 2012 to 2014; and Intranasal Therapeutics, Inc. from 2005 to 2006. Ms. Giles also founded Optivara, Inc., a sister company to GAC, and served as Chief Executive Officer from 2013 to 2019. Prior to founding GAC, Ms. Giles held the position of Vice President of Strategy Development for G.D. Searle Pharmaceuticals, a division of Monsanto, and served in various leadership roles with Abbott Laboratories. Ms. Giles received a B.S. from Juniata College and completed executive management programs at Stanford University and the University of Chicago.